Literature DB >> 2029992

Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features.

D K Freese1, D C Snover, H L Sharp, C R Gross, S K Savick, W D Payne.   

Abstract

In an effort to better understand chronic liver transplant rejection, we studied 110 children and adults who survived for at least 2 mo after the transplant procedure. Chronic rejection was defined using a combination of clinical and histopathological criteria and was diagnosed in 10 of the 110 patients for an incidence of 9.1%. All 10 patients were children with the mean age 3.4 yr vs. 21.7 yr for patients without chronic rejection (p less than .001). Males and females were equally represented, and nine received a liver from a gender-matched donor. Four patients were non-Caucasian, resulting in an incidence of 21.7% in non-Caucasian recipients vs. 6.6% in Caucasian recipients (p less than .05). All chronic rejection patients received a liver from an ABO-compatible donor. T-cell crossmatch was negative in all patients in whom it was assessed, and no significant disparity in either the class I or class II human leukocyte antigen loci was noted. Patients who had chronic rejection experienced acute rejection earlier, 11 days vs. 16 days (p less than .05), than patients who did not. In 8 of 10 patients, chronic rejection appeared to evolve directly from early episodes of acute rejection that were unresponsive to immunosuppressive therapy. Two distinct histological presentations were noted. One was progressive loss of bile ducts without hepatocellular injury (four patients), and the other was characterized by worsening ischemic hepatocellular damage and fibrosis (six patients) in addition to severe ductular injury. The first was associated with a more benign clinical course, the second with rapidly deteriorating hepatic function. Three patients recovered spontaneously 9 to 14 mo after transplant, one died awaiting a donor for retransplant, and five had retransplants. We conclude that chronic rejection after the operation is a relatively uncommon complication of liver transplantation with a variable clinical course and unpredictable outcome.

Entities:  

Mesh:

Year:  1991        PMID: 2029992

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

1.  Caring for the liver transplant recipient.

Authors:  R K Zetterman
Journal:  Curr Gastroenterol Rep       Date:  1999-06

Review 2.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

3.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05

4.  Risk factors for liver rejection: evidence to suggest enhanced allograft tolerance in infancy.

Authors:  M S Murphy; R Harrison; P Davies; J A Buckels; A D Mayer; S Hubscher; D A Kelly
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

5.  CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.

Authors:  Vyacheslav Palchevskiy; Ying Ying Xue; Rita Kern; Stephen S Weigt; Aric L Gregson; Sophie X Song; Michael C Fishbein; Cory M Hogaboam; David M Sayah; Joseph P Lynch; Michael P Keane; David G Brooks; John A Belperio
Journal:  JCI Insight       Date:  2019-05-14

6.  Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation.

Authors:  Yu Jin Kim; Kyu Taek Lee; Young Cheol Jo; Kwang Hyuck Lee; Jong Kyun Lee; Jae-Won Joh; Choon Hyuck David Kwon
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 7.  Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rinkesh K Bansal; Neeraj Saraf; Dheeraj Gautam; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-11-07

8.  Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.

Authors:  O Bronsther; R Mañez; S Kusne; W Irish; W Roland; A Jain; R Llull; A J Demetris; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

9.  Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.

Authors:  J G Lunz; S Contrucci; K Ruppert; N Murase; J J Fung; T E Starzl; A J Demetris
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

10.  Transjugular intrahepatic portosystemic shunt in liver transplant recipients.

Authors:  Armin Finkenstedt; Ivo W Graziadei; Karin Nachbaur; Werner Jaschke; Walter Mark; Raimund Margreiter; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.